The global life sciences industry continues to see extraordinary growth. COVID-19 magnified the importance of digital advances as the sector raced to provide new testing, vaccines and treatment. It was also the catalyst for long-lasting changes in working habits and patient treatment. The growing and aging global population needs an increasing supply of medicines delivered faster and more cheaply than ever before.

As a result, we are seeing a major shift in life sciences client requirements for project delivery as the industry seeks to build the next generation of facilities to support product development at pace. Soaring investment in both laboratory and manufacturing space is ramping up pressure on the industry to deliver projects more efficiently to keep pace with surging demand.

In this report, we explore the changing dynamics in the life sciences sector globally, harnessing insights from key datapoints which illuminate trends in construction costs and industry sentiment.